Insulin delivery devices are used for titrated and
accurate delivery of insulin. Diabetes type I being a chronic disease requires
a lifelong treatment with insulin which has resulted in the development of less
painful and less invasive delivery systems.
The growth of the insulin delivery market can be
attributed to factors such as high returns on investment, favorable
reimbursement scenario, demand for non-invasive delivery systems, technological
advancements in insulin delivery devices, growing diabetic population, rising
awareness and others. The constraining factors are cost of the insulin delivery
devices, presence of low cost manufacturers especially China and others.
On the basis of type, the insulin delivery devices
market is segmented into insulin syringes, insulin pump, insulin pens, insulin
jet injectors and others devices (jet injectors, transdermal patches, and
inhalers). The insulin pens segment is further sub segmented into disposable
pens and reusable pens with the reusable segment commanded the largest share of
insulin’s pens market in 2016. The pumps segment is further sub-segmented into
external pumps and internal pumps with external pumps commanding in the largest
share of the insulin pumps market in 2016.
The global insulin delivery devices market and is
expected to reach $14.21 billion by 2020, growing at an impressive rate of 7.9
% CAGR.
Segmentation
Insulin
Delivery Devices market has been segmented on the basis of type which comprises
of Insulin Syringe, Insulin Pumps, Insulin Pens, Insulin Jet Injectors.
Regional
Analysis
The
developed regions of North America and Europe are expected to lead the insulin
delivery market. The U.S is expected to lead the world due to its higher per
capita income and its faster uptake of technology. U.S. also spends a higher
GDP on its healthcare which accounts to a whopping 16% in 2016
However
the market is expected to shift towards the developing regions of Asian Pacific
in the near future. The Asia pacific region is expected to be led by India.
India is called the diabetes capital of the world with as many as 50 million
diabetes patients. Of the two types of diabetes India has more number of
patients with type-2 diabetes. India has also witnessing an alarming rise in
incidence of diabetes. The World Health Organizations estimates the global
burden of type-2 diabetes to increase to 438 million by 2030 from 285 million
people. For the diabetes treatment players in India this means a pie of 87
million patients in 2030. Other Asia Pacific nations expected to drive growth
in the future are Vietnam, Indonesia and China.
Europe
is expected to be led by Germany due to presence of its large medical device
industry. However it has to be noted that southern Europe has a higher
prevalence of
diabetes.
Countries such as Spain, Italy and Portugal are expected to have a higher
growth of the insulin delivery devices market. Another nation which has a large
unserved market is Turkey.
Middle
East is another lucrative market due to its higher wealth. African region is
however expected to be laggard due to poor socio economic conditions and
geopolitical issues.
Browse
Complete Report Details @ https://www.marketresearchfuture.com/reports/insulin-delivery-devices-market-851
Intended Audience
· Insulin
Delivery Device manufacturers and suppliers
·
Contract
Research Organizations (CROs)
·
Research
and Development (R&D) Companies
·
Government
and Independent Regulatory Authorities
·
Market
Research and Consulting Service Providers
·
Academic
Institutes and Universities
Major Table of Content
1 Research Scope and Methodology
1.1 Market Definition 11
1.2 Market Breakdown By Type
11
1.3 Market Breakdown By
Geography 11
1.4 Research Methodology And
Sources 12
2 Executive Summary
2.1 Key Findings 14
2.2 Research Summary 14
3 Market Dynamics
3.1
Introduction 16
3.2
Trends In The Market 18
TOC
Continued….!
About
US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone:
+1
646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment